Fundz

Who to call at Valink Therapeutics, and when

Fundz watches for the moments Valink Therapeutics starts buying, and tells you who to reach.

  • An alert the day Valink Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Valink Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Valink Therapeutics and Nona Biosciences Establish Strategic Alliance to Enhance Biologics Discovery.

Dec 17, 2025

Contract Type

partnership

BostonBiotechnologyHealth CareTherapeutics

Description

Valink Therapeutics and Nona Biosciences have formed a strategic alliance named 'Biology to Bispecific' (B2B)™ to accelerate the discovery of novel bispecific antibodies and ADCs. This collaboration will combine Valink's LiliumX™ discovery platform with Nona's Harbour Mice® fully human antibodies to generate new drug candidates.

Company Information

Company

Valink Therapeutics

Location

Boston, Massachusetts, United States

About

Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.

Related People

Irsyad
Likely contact at this company
••••••••@••••••••

See Irsyad's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Valink Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Valink Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.